Iqvia Holdings Inc (IQV) stock saw a decline, ending the day at $205.42 which represents a decrease of $-0.27 or -0.13% from the prior close of $205.69. The stock opened at $205.51 and touched a low ...

On the technical front, EUR/USD remains under pressure. Immediate support lies at 1.0176, the YTD low from January 13, with ...

SonicWall is warning customers of a critical vulnerability that was potentially already exploited as a zero-day.

Biogen’s applications for the higher dose regimen of spinal muscular atrophy (SMA) drug Spinraza are now under review in the US and Europe.

Entegris Inc (ENTG) stock saw a modest uptick, ending the day at $107.19 which represents a slight increase of $0.46 or 0.43% from the prior close of $106.73. The stock opened at $107.61 and touched a ...

The EUR/GBP pair edged lower on Thursday, slipping to 0.8445 as it drifts closer to the 200-day Simple Moving Average (SMA), positioned around 0.8420.

After a slow start to the year, U.S. equities have surged to new record highs following President Trump’s inauguration. By Wednesday’s close, the SPDR S&P 500 ETF Trust (NYSE: SPY) had gained over 4% ...

In a good-news-bad-news week for Biogen, the company will cut an undisclosed number of employees, just as a higher dose of ...

Denmark has told Donald Trump in no uncertain terms what it thinks of his offer to acquire Greenland, but the USA will likely avoid expletives from Martian life when making good on another of its new ...

Spinraza remains a big product for Biogen but has seen its sales go into reverse as competition in SMA treatment has emerged ...

CAMBRIDGE, Mass. - Biogen Inc. (NASDAQ:BIIB), a $20.8 billion biotechnology company with a robust 75.6% gross profit margin, ...

Biogen Inc. (BIIB) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted the company's supplemental New ...